Nine Vanderbilt students will pitch their startup ideas before a panel of judges, Wednesday, April 9. The students were selected through Flash Pitch '14, a student startup idea challenge hosted by CTTC. The students selected to pitch are:
The primary role of CTTC is to transfer innovative products and technology out of the university. We want the public to benefit from the brilliant work happening inside Vanderbilt's labs and research centers.
The Adventures of Jasper Woodbury is a software-based learning tool that helpsstudents conquer mathematical problem solving skills through project-based learning -- a teaching method that asks students to identify and solve real-world problems. The Jasper series was developed by researchers at Vanderbilt University Peabody College of Education and Human Development and is the culmination of several years of effort to create enriched learning environments that foster the development of mathematics problem-solving skills. Watch the short video below to learn more. Click here if you are interested in purchasing the software.
The second installment of Driving Innovation Forward, CTTC's newsletter is out. This issue includes a video of featured inventor Paul Harris, information about an upcoming SBIR/STTR workshop, and details about Vanderbilt's new automated system for transferring and processing Material Transfer Agreements. Check it out below.
Vanderbilt University's popular VUCast recently took a tour inside The Zwiebel Lab, led by Vanderbilt Professor Dr. Larry Zwiebel. The major focus of The Zwiebel Lab is to characterize specific genes and their products that control important behavioral processes in the life cycle of insects known to transmit diseases to humans.
Each year, thousands of technology transfer officers convene with professionals from a variety of industries to discuss new technologies, trends in commercialization, best practices, and lessons learned at the Association of University Technology Managers (AUTM) annual conference.
Fifty years ago, the month of February was declared National Heart Month by then-president Lyndon B. Johnson. As recently shared in VUMC’s Reporter, the progress made in diagnosing and treating heart disease is remarkable.
Tuesday, Feb. 4, roughly 50 Vanderbilt University graduate and professional students - from the engineering, medical, law and business schools - convened at the Owen Graduate School of Management to hear pitches for five new Vanderbilt inventions that will be the focus of the 2014 Tech Venture Challenge. At the kickoff event, students listened to descriptions of the five Vanderbilt technologies:
“Despite exciting advances, this Report shows that cannot treat our way out of the cancer problem,” said Dr. Christopher Wild, Director of International Agency for Research on Cancer (IARC) and co-editor of the World Cancer Report 2014, in a news release issued by the World Health Organization. “More commitment to prevention and early detection is desperately needed in order to complement improved treatments and address the alarming rise in cancer burden globally.”
As posted recently in MyVU News, nine Vanderbilt University faculty members, two of whom are active inventors, were honored for their academic achievements, including their recent naming to endowed chairs. Congratulations to the following:
"Nashville venture capital investments surge 28% in 2013" read the headline of a Nashville Business Journal article late last week. According to The MoneyTree Report, venture capitalists invested $93.4 milion in 42 deals, $14.5 million more than the preceding year.
Novo Nordisk, a world leader in diabetes innovation, recently announced a new opportunity for research funding and industry partnership. The Novo Nordisk Diabetes and Obesity Biologics Science Forum Program is now accepting applications from researchers at a limited to a number of leading U.S.
The year 2013 has been an eventful one for CTTC. From an Entrepreneur Boot Camp to an SBIR/STTR workshop, participation in the NSF Innovation Corps program to agreements with new industry partners, we had a lot to blog about. Here’s a look back at the 13 most read posts from 2013:
Three Vanderbilt technologies received US patent protection in the month of November. One invention includes a compound that targets positive allosteric modulation of the mGlu5 receptor for the treatment of neurological and psychiatric disorders. It was developed at Vanderbilt Center for Neuroscience Drug Discovery which is led by Vanderbilt neuroscientist P.